The compound CMX521 significantly reduced lung viral titer and symptoms in a SARS-CoV-2 mouse model, as reported by biomedical company Chimerix in collaboration with the Rapidly Emerging Antiviral Drug Development…
Covid-19 / Coronavirus, Immunology And Microbiology, Infectious Diseases, News, Research
David Wohl, MD, provides an overview of two COVID oral therapeutics, Paxlovid and Molnupiravir. We are receiving increasing supplies of these medications and want to ensure all clinicians know when…
Lauren Raff, MD, Adult Associate Trauma Medical Director talks with the News and Observer about the latest wave of COVID-19 and how it has affected seriously-ill COVID-positive patients inside the…
Current therapeutic options and resources to aid appropriate selection.
Covid-19 / Coronavirus, Infectious Diseases, Pharmacology, Vital Signs
Join the UNC Program for Precision Medicine in Health Care (PPMH) for Precision Medicine Approaches to Addressing COVID-19, a free virtual mini-symposium from 1:00-3:00pm on Wednesday February 23, 2022. Presenters…
Announcements, Covid-19 / Coronavirus, Infectious Diseases, School of Medicine, Vital Signs
The UNC School of Medicine’s Zachary Willis, MD, MPH, co-authored an editorial published in the British Medical Journal in conjunction with new research that shows dramatic reductions in hospital admissions…
Covid-19 / Coronavirus, News, School of Medicine, Vital Signs
Dirk Dittmer, PhD, explains how UNC-led CORVASEQ program helps to track the spread and development of variants like Omicron in North Carolina.
Covid-19 / Coronavirus, News, School of Medicine, Vital Signs
The NC Child Hunger Leaders Conference will return for its 11th annual event on Thursday, Feb. 17, 2022.
Announcements, Covid-19 / Coronavirus, News, Nutrition, Pediatrics And Children's Health, Vital Signs
The Eshelman Institute for Innovation recently opened its pre-proposal application for the 2022 annual grant cycle. The Institute seeks to fund translational research related to therapeutics focused on oncology, infectious…
Announcements, Awards, Rankings and Recognitions, Bioinformatics, Cancer, Clinical Research, Covid-19 / Coronavirus, Diversity, Equity and Inclusion, Education, Events, Faculty, General Medicine, Global Health, Health Sciences, Infectious Diseases, Neurology, News, North Carolina, Oncology, Physical Medicine & Rehabilitation, Physical Therapy, Pulmonology, Research, School of Medicine, Technology and Innovation, UNC Health, Vital Signs, Wellness
The Coronavirus Variant Sequencing (CORVASEQ) Surveillance Program, led by a team of UNC researchers, has detected the Omicron SARS-CoV-2 variant in North Carolina. Together, members of the program at UNC-Chapel…
Covid-19 / Coronavirus, News, Research, School of Medicine, UNC Health, Vital Signs
COVID-19 vaccines are safe and effective for pregnant people and their developing baby. Hear expert advice from Alexa Mieses Malchuk, MD, about staying protected.
On Wednesday, UNC Health experts David Wohl, and Melissa Miller met with the media to answer questions and offer their expertise regarding what we know so far about the Omicron…
Covid-19 / Coronavirus, News, Research, School of Medicine, UNC Health, Vital Signs
The Duke Clinical Research Institute (DCRI), Center for Health Equity Research at UNC-Chapel Hill (UNC-CHER), and Community-Campus Partnerships for Health (CCPH) today announced plans to deliver their You & Me…
Covid-19 / Coronavirus, Infection Prevention, Infectious Diseases, News, Social Medicine, Vital Signs
Giselle Corbie, CHER Director, has co-authored an opinion piece for STAT with Warren Kibbe of the Duke Cancer Institute, calling for engaging communities “around how and why data affect them.”
Emily Pfaff, PhD, is Co-director of Informatics and Data Science at NC TraCS. She has a PhD in Health Informatics and a master’s in Information Science, both from UNC. Her…
Covid-19 / Coronavirus, Faculty, Infectious Diseases, Vital Signs
A single dose of REGEN-COV, a combination monoclonal antibody therapy, reduced the risk of COVID-19 by 81.6% several months after a single dose. UNC School of Medicine’s Myron Cohen, MD,…
UNC Rex Cardiologist Christopher Kelly, MS, MD, RPVI, CBCCT, takes his children to get vaccinated at UNC Family Medicine at Panther Creek in Cary.
Covid-19 / Coronavirus, Infection Prevention, News, Vital Signs
Gracie Howell, Moderna COVID-19 vaccine clinical trial participant, continues her journey. Hear her story as she returns nine months later to receive her booster shot and why she values participating…
Clinical Research, Covid-19 / Coronavirus, Infectious Diseases, News, Research
University of North Carolina at Chapel Hill research set the stage to seek emergency authorization of the first oral antiviral drug to treat COVID-19, a pill developed by the pharmaceutical…
The System Anti-Infective P&T Subcommittee has approved a formulary restriction for ivermectin (Stromectol). As of Sept. 21, 2021, ivermectin is RESTRICTED to FDA-approved indications only.
